Biogen Idec Launches New Avonex® Nurse Services Program (M


Biogen Idec (NASDAQ: BIIB) announced today the national launch of the new AVONEX® (Interferon beta-1a) Nurse Services program which is designed to help people with multiple sclerosis (MS) as they begin and continue treatment with AVONEX, the most prescribed treatment for relapsing forms of MS worldwide. [click link for full article]

Read more...